Liberta Co.,Ltd.
Liberta Co.,Ltd. (4935.T) Financial Performance & Income Statement Overview
Explore the financials of Liberta Co.,Ltd. (4935.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Liberta Co.,Ltd. (4935.T) Income Statement & Financial Overview
Review Liberta Co.,Ltd. 4935.T income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.60B | $2.44B | $2.01B | $2.53B |
| Cost of Revenue | $991.85M | $1.44B | $1.19B | $1.57B |
| Gross Profit | $609.21M | $1.008B | $818.00M | $959.88M |
| Gross Profit Ratio | $0.38 | $0.41 | $0.41 | $0.38 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $785.67M | $912.00M | $803.00M | $802.00M |
| Operating Expenses | $785.67M | $913.00M | $803.00M | $815.66M |
| Total Costs & Expenses | $1.78B | $2.35B | $2.00B | $2.38B |
| Interest Income | $251000.00 | $75000.00 | $106000.00 | $69000.00 |
| Interest Expense | $9.74M | $8.11M | $8.68M | $7.43M |
| Depreciation & Amortization | $44.70M | $44.75M | $34.25M | $45.77M |
| EBITDA | -$130.50M | $140.75M | $52.77M | $191.84M |
| EBITDA Ratio | -$0.08 | $0.06 | $0.03 | $0.08 |
| Operating Income | -$176.46M | $95.00M | $15.00M | $144.22M |
| Operating Income Ratio | -$0.11 | $0.04 | $0.007 | $0.06 |
| Other Income/Expenses (Net) | -$8.47M | -$1.00M | -$15.00M | -$5.59M |
| Income Before Tax | -$184.93M | $94.00M | -$793000.00 | $138.64M |
| Income Before Tax Ratio | -$0.12 | $0.04 | -$0.00 | $0.05 |
| Income Tax Expense | -$56.84M | $45.00M | $8.00M | $57.20M |
| Net Income | -$128.09M | $49.00M | -$8.00M | $81.39M |
| Net Income Ratio | -$0.08 | $0.02 | -$0.004 | $0.03 |
| EPS | -$21.43 | $8.20 | -$1.34 | $13.63 |
| Diluted EPS | -$21.43 | $8.20 | -$1.34 | $13.63 |
| Weighted Avg Shares Outstanding | $5.98M | $5.98M | $5.98M | $5.97M |
| Weighted Avg Shares Outstanding (Diluted) | $5.98M | $5.98M | $5.98M | $5.97M |
Over the past four quarters, Liberta Co.,Ltd. demonstrated steady revenue growth, increasing from $2.53B in Q2 2024 to $1.60B in Q1 2025. Operating income reached -$176.46M in Q1 2025, maintaining a consistent -11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$130.50M, reflecting operational efficiency. Net income dropped to -$128.09M, with EPS at -$21.43. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan